Filter
26
Filtered Results: 26
Text search:
molnupiravir
Featured
Recommendations
9
Language
Document type
Guidelines
11
Fact sheets
6
Studies & Reports
5
Strategic & Response Plan
2
Manuals
1
Resource Platforms
1
Countries / Regions
Ukraine
3
Latin America and the Carribbean
3
Global
2
El Salvador
1
Africa
1
Paraguay
1
Authors & Publishers
Publication Years
Category
COVID-19
7
Guidelines
3
Infection Control & Prevention (IPC)
1
Medical Devices & Equipment
1
Humanitarian Crisis
1
Health Systems
1
Pharmacy & Technologies
1
Toolboxes
Clinical Guidelines
14
Country specific documents
2
COVAX Initiative
2
Public Health
1
Global Impact: Socio-economic, health services, TB & HIV
1
Scientific & Research Studies
1
Hospital Readiness/Essential Health Services
1
Access & Strategy
1
Fair Allocation & Ethical Aspects
1
SARS-CoV-2 Variants
1
Essential Medicines
1
Prices and Patents
1
Ukraine
1
Situation Reports & Updates
1
Appeals & Response Plans
1
Global Overview
1
Human Rights & the Right to Health
1
Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and priority prevention programmes, and laying the foundation for longer-term health systems recov...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
Technical guidelines for the comprehensive care of patients with COVID-19 ; second version
